Pembrolizumab,Lenvatinib,Sunitinib,Everolimus
Merck,Pfizer,eisai
['sunitinib', 'kcsm,(-skcsm)', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva']
thomas e. hutson, do, pharmd, on rcc: overall survival analysis of lenvatinib, pembrolizumab, and sunitinib #kcsm #kidneycancer #rcc #oncology #asco23 
News and views from the world of clinical oncology and hematology